Provectus Biopharmaceuticals Inc (PVCT)
0.1964
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Provectus Biopharmaceuticals Shareholders Equity (Quarterly): -7.593M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -7.593M |
September 30, 2023 | -7.519M |
June 30, 2023 | -7.297M |
March 31, 2023 | -7.002M |
December 31, 2022 | -6.228M |
September 30, 2022 | -6.859M |
June 30, 2022 | -6.147M |
March 31, 2022 | -5.069M |
December 31, 2021 | -4.187M |
September 30, 2021 | -2.949M |
June 30, 2021 | -2.611M |
March 31, 2021 | -31.62M |
December 31, 2020 | -30.21M |
September 30, 2020 | -28.71M |
June 30, 2020 | -27.48M |
March 31, 2020 | -25.87M |
December 31, 2019 | -24.07M |
September 30, 2019 | -22.59M |
June 30, 2019 | -20.97M |
March 31, 2019 | -18.80M |
December 31, 2018 | -17.42M |
September 30, 2018 | -15.29M |
June 30, 2018 | -13.70M |
March 31, 2018 | -12.50M |
December 31, 2017 | -10.02M |
Date | Value |
---|---|
September 30, 2017 | -7.309M |
June 30, 2017 | -4.215M |
March 31, 2017 | -0.9203M |
December 31, 2016 | 3.469M |
September 30, 2016 | 5.310M |
June 30, 2016 | 9.140M |
March 31, 2016 | 14.18M |
December 31, 2015 | 16.32M |
September 30, 2015 | 24.53M |
June 30, 2015 | 30.25M |
March 31, 2015 | 21.70M |
December 31, 2014 | 25.19M |
September 30, 2014 | 19.54M |
June 30, 2014 | 19.98M |
March 31, 2014 | 14.52M |
December 31, 2013 | 6.629M |
September 30, 2013 | 8.723M |
June 30, 2013 | 6.347M |
March 31, 2013 | 5.457M |
December 31, 2012 | 4.394M |
September 30, 2012 | 3.424M |
June 30, 2012 | 4.864M |
March 31, 2012 | 6.188M |
December 31, 2011 | 10.02M |
September 30, 2011 | 12.17M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-31.62M
Minimum
Mar 2021
-2.611M
Maximum
Jun 2021
-14.47M
Average
-7.519M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
Insmed Inc | -331.92M |
NeuroMetrix Inc | 20.09M |
Intra-Cellular Therapies Inc | 591.42M |
Rhythm Pharmaceuticals Inc | 169.76M |
Amylyx Pharmaceuticals Inc | 433.43M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.449M |
Total Liabilities (Quarterly) | 9.042M |